Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
2017 · Acta Pharmaceutica Sinica B · 33 citations
https://doi.org/10.1016/j.apsb.2017.07.004
R
Ruihua Dong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
389
Citations
11
h-index
12
i10-index
Ruihua Dong is an academic researcher from Capital Medical University. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Drug Transport and Resistance Mechanisms & Cancer Immunotherapy and Biomarkers. The author has an h-index of 11, co-authored 34 publications.
ORCID: 0000-0003-3463-5023Papers by this author
worksPharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder
2019 · Drugs in R&D · 21 citations
https://doi.org/10.1007/s40268-019-0277-9
Development of a novel UHPLC-MS/MS method for quantitative analysis of pirtobrutinib in rat plasma: application to pharmacokinetic study
2025 · BMC Chemistry · 2 citations
https://doi.org/10.1186/s13065-025-01424-2
Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects
2024 · Drug Design Development and Therapy · 0 citations
https://doi.org/10.2147/dddt.s481481
Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013–2022)
2025 · BMC Pharmacology and Toxicology · 0 citations
https://doi.org/10.1186/s40360-025-00905-3
Safety, immunogenicity, persistence and dose evaluation of the CS-2034 mRNA COVID-19 vaccine: a phase II randomized controlled trial in healthy Chinese adults
2025 · BMC Infectious Diseases · 0 citations
https://doi.org/10.1186/s12879-025-12053-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat